Methamphetamine induces striatal neurokinin-1 receptor endocytosis primarily in somatostatin/NPY/NOS interneurons and the role of dopamine receptors in mice

Synapse

Volumn 65, Issue 4, 2011, Pages 300-308

  Wang, Jing ^a   Angulo, Jesus A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Dopamine receptors; Endocytosis; Interneuron; Methamphetamine; Neurokinin 1 receptor; Striatum

Indexed keywords

17ALPHA ETHYNYL 17BETA HYDROXY 5ALPHA ANDROSTANO[3,2 B]PYRIMIDO[1,2 A]BENZIMIDAZOLE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; METHAMPHETAMINE; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE Y; NITRIC OXIDE SYNTHASE; RACLOPRIDE; SOMATOSTATIN; SUBSTANCE P;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; CYTOPLASM; ENDOCYTOSIS; ENDOSOME; HISTOLOGY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INTERNEURON; MALE; MOUSE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; ENDOCYTOSIS; INTERNEURONS; MALE; METHAMPHETAMINE; MICE; MICE, INBRED ICR; NEUROPEPTIDE Y; NITRIC OXIDE SYNTHASE; RECEPTORS, DOPAMINE; RECEPTORS, NEUROKININ-1; SOMATOSTATIN;

EID: 79251572354     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20848     Document Type: Article

References (55)

1. Adams DH, Hanson GR, Keefe KA. 2001. Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum. Neuroscience 102: 843-851.
2. Angulo JA, McEwen BS. 1994. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res Brain Res Rev 19: 1-28.
3. Barak LS, Warabi K, Feng X, Caron MG, Kwatra MM. 1999. Real-time visualization of the cellular redistribution of G protein-coupled receptor kinase 2 and β-arrestin 2 during homologous desensitization of the substance P receptor. J Biol Chem 274: 7565-7569.
4. Baucum AJ, II, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE. 2004. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism. J Neurosci 24: 3436-3443.
5. Carey JT, Mandel J. 1968. A San Francisco Bay Area "speed" scene. J Health Soc Behav 9: 164-174.
6. Dawson TM, Sasaki M, Gonzalez-Zulueta M, Dawson VL. 1998. Regulation of neuronal nitric oxide synthase and identification of novel nitric oxide signaling pathways. Prog Brain Res 118: 3-11.
7. Deng X, Wang Y, Chou J, Cadet JL. 2001. Methamphetamine causes widespread apoptosis in the mouse brain: Evidence from using an improved TUNEL histochemical method. Brain Res Mol Brain Res 93: 64-69.
8. Eisch AJ, Marshall JF. 1998. Methamphetamine neurotoxicity: Dissociation of striatal dopamine terminal damage from parietal cortical cell body injury. Synapse 30: 433-445.
9. Ellinwood EH, Jr. 1971. Assault and homicide associated with amphetamine abuse. Am J Psychiatry 127: 1170-1175.
10. Euler UA, Gaddum JH. 1931. An unidentified depressor substance in certain tissue extracts. J Physiol (Lond) 72: 74-87.
11. Franklin KBJ, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. New York: The Academic Press.
12. Fridovich I. 1986. Biological effects of the superoxide radical. Arch Biochem Biophys 247: 1-11.
13. Gerfen CR. 1992. The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 15: 285-320.
14. Hanson GR, Gibb JW, Metzger RR, Kokoshka JM, Fleckenstein AE. 1998. Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: Oxidative consequences. Ann NY Acad Sci 844: 103-107.
15. Hawks D, Mitcheson M, Ogborne A, Edwards G. 1969. Abuse of methylamphetamine. Br Med J 1: 715-21.
16. Hokfelt T, Kellerth JO, Nilsson G, Pernow B. 1975. Substance P localization in the central nervous system and in some primary sensory neurons. Science 190: 889-890.
17. Holzer P, Holzer-Petsche U. 1997a. Tachykinins in the gut, Part 1. Expression, release and motor function. Pharmacol Ther 73: 173-217.
18. Holzer P, Holzer-Petsche U. 1997b. Tachykinins in the gut, Part 2. Roles in neural excitation, secretion and inflammation. Pharmacol Ther 73: 219-263.
19. Imam SZ, Ali SF. 2001. Ageing increases the susceptibility to methamphetamine-induced dopaminergic neurotoxicity in rats: Correlation with peroxynitrite production and hyperthermia. J Neurochem 78: 952-959.
20. Imam SZ, Newport GD, Itzhak Y, Cadet JL, Islam F, Slikker W, Jr, Ali SF. 2001. Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: Evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J Neurochem 76: 745-749.
21. Itzhak Y, Ali SF. 1996. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem 67: 1770-1773.
22. Jones SR, Gainetdinov RR, Wightman RM, Caron MG. 1998. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18: 1979-1986.
23. Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC. 1995. Striatal interneurons-chemical, physiological and morphological characterization. Trends Neurosci 18: 527-535.
24. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Swain CJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NM. 1998. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281: 1640-1645.
25. Krasnova IN, Cadet JL. 2009. Methamphetamine toxicity and messengers of death. Brain Res Rev 60: 379-407.
26. Le Moine C, Tison F, Bloch B. 1990. D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum. Neurosci Lett 117: 248-252.
27. Mantyh PW, Demaster E, Malhotra A, Ghilardi JR, Rogers SD, Mantyh CR, Liu H, Basbaum AI, Vigna SR, Maggio JE, Simone DA. 1995a. Receptor endocytosis and dendritic reshaping in spinal neurons after somatosensory stimulation. Science 268: 1629-1632.
28. Mantyh PW, Allen CJ, Ghilardi JR, Rogers SD, Mantyh CR, Liu H, Basbaum AI, Vigna SR, Maggio JE. 1995b. Rapid endocytosis of a G protein-coupled receptor: Substance P-evoked internalization of its receptor in the rat striatum in vivo. Proc Natl Acad Sci USA 92: 2622-2626.
29. McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA. 1998. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [11C]WIN-35428. J Neurosci 18: 8417-8422.
30. McConalogue K, Dery O, Lovett M, Wong H, Walsh JH, Grady EF, Bunnett NW. 1999. Substance P-induced trafficking of β-arrestins. J Biol Chem 274: 16257-16268.
31. Nash JF, Yamamoto BK. 1992. Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3, 4-methylenedioxymethamphetamine. Brain Res 581: 237-243.
32. O'shaughnessy MC, Vetsika EK, Inglis JJ, Carlesson J, Haigh R, Kidd BL, Winyard PG. 2006. The effect of substance P on nitric oxide release in a rheumatoid arthritis model. Inflamm Res 55: 236-240.
33. Oku R, Satoh M, Takagi H. 1987. Release of substance P from the spinal dorsal horn is enhanced in polyarthritic rats. Neurosci Lett 74: 315-319.
34. Pu C, Broening HW, Vorhees CV. 1996. Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex. Synapse 23: 328-334.
35. Ralevic V, Khalil Z, Helme RD, Dusting GJ. 1995. Role of nitric oxide in the actions of substance P and other mediators of inflammation in rat skin microvasculature. Eur J Pharmacol 284: 231-239.
36. Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY. 1982. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 235: 93-103.
37. Ricaurte GA, Seiden LS, Schuster CR. 1984. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res 303: 359-364.
38. Ryan LJ, Linder JC, Martone ME, Groves PM. 1990. Histological and ultrastructural evidence that D-amphetamine causes degeneration in neostriatum and frontal cortex of rats. Brain Res 518: 67-77.
39. Schmidt CJ, Gibb JW. 1985. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: Effects of amfonelic acid. Eur J Pharmacol 109: 73-80.
40. Seiden LS, MacPhail RC, Oglesby MW. 1975. Catecholamines and drug-behavior interactions. Fed Proc 34: 1823-1831.
41. Sonsalla PK, Gibb JW, Hanson GR. 1986. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J Pharmacol Exp Ther 238: 932-937.
42. +-stimulated release of acetylcholine from rat neostriatum. Brain Res 250: 263-270.
43. Szuster RR. 1990. Methamphetamine in psychiatric emergencies. Hawaii Med J 49: 389-391.
44. Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED. 2004. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24: 6028-6036.
45. Volkow ND, Chang L, Wang G-J, Fowler JS, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding Y-S, Wong C, Logan J. 2001a. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychol 158: 383-389.
46. Volkow ND, Chang L, Wang G-J, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding Y-S, Logan J, Wong C, Miller EN. 2001b. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychol 158: 377-382.
47. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ. 1996. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Med 2: 699-703.
48. Woolverton WL, Ricaurte GA, Forno LS, Seiden LS. 1989. Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res 486: 73-78.
49. Xu W, Zhu JPQ, Angulo JA. 2005. Induction of striatal pre- and post-synaptic damage by methamphetamine requires the dopamine receptors. Synapse 58: 110-121.
50. Yamamoto BK, Bankson MG. 2005. Amphetamine neurotoxicity: Cause and consequence of oxidative stress. Critical Rev Neurobiol 17: 87-117.
51. Yu J, Cadet JL, Angulo JA. 2002. Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain. J Neurochem 83: 613-622.
52. Yu J, Wang J, Cadet JL, Angulo JA. 2004. Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain. Brain Res 1007: 124-131.
53. Zhu JPQ, Xu W, Angulo JA. 2005. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice. Brain Res 1049: 171-181.
54. Zhu JPQ, Xu W, Angulo JA. 2006. Methamphetamine-induced cell death: Selective vulnerability in neuronal subpopulations of the striatum in mice. Neurosci 140: 607-622.
55. Zhu JPQ, Xu W, Wang J, Ali SF, Angulo JA. 2009. The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice. J Neurochem 111: 656-668.